114 related articles for article (PubMed ID: 10448291)
1. Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
Woll PJ; Judson I; Lee SM; Rodenhuis S; Nielsen OS; Buesa JM; Lorigan PC; Leyvraz S; Hermans C; van Glabbeke M; Verweij J
Eur J Cancer; 1999 Mar; 35(3):410-2. PubMed ID: 10448291
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas.
Garcia del Muro X; Lopez-Pousa A; Martin J; Buesa JM; Martinez-Trufero J; Casado A; Poveda A; Cruz J; Bover I; Maurel J;
Cancer; 2005 Oct; 104(8):1706-12. PubMed ID: 16134177
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma.
Talbot SM; Keohan ML; Hesdorffer M; Orrico R; Bagiella E; Troxel AB; Taub RN
Cancer; 2003 Nov; 98(9):1942-6. PubMed ID: 14584078
[TBL] [Abstract][Full Text] [Related]
4. A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas.
Trent JC; Beach J; Burgess MA; Papadopolous N; Chen LL; Benjamin RS; Patel SR
Cancer; 2003 Dec; 98(12):2693-9. PubMed ID: 14669291
[TBL] [Abstract][Full Text] [Related]
5. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients.
van Oosterom AT; Mouridsen HT; Nielsen OS; Dombernowsky P; Krzemieniecki K; Judson I; Svancarova L; Spooner D; Hermans C; Van Glabbeke M; Verweij J;
Eur J Cancer; 2002 Dec; 38(18):2397-406. PubMed ID: 12460784
[TBL] [Abstract][Full Text] [Related]
6. Preoperative intensity-modulated radiotherapy combined with temozolomide for locally advanced soft-tissue sarcoma.
Jakob J; Wenz F; Dinter DJ; Ströbel P; Hohenberger P
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):810-6. PubMed ID: 19307066
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of temozolomide using an extended continuous oral schedule.
Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
[TBL] [Abstract][Full Text] [Related]
8. A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma.
van Meerbeeck JP; Baas P; Debruyne C; Smit EF; van Klaveren RJ; Galdermans D; Lentz MA; Manegold C; Giaccone G;
Eur J Cancer; 2002 Apr; 38(6):779-83. PubMed ID: 11937311
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial.
Le Cesne A; Blay JY; Judson I; Van Oosterom A; Verweij J; Radford J; Lorigan P; Rodenhuis S; Ray-Coquard I; Bonvalot S; Collin F; Jimeno J; Di Paola E; Van Glabbeke M; Nielsen OS
J Clin Oncol; 2005 Jan; 23(3):576-84. PubMed ID: 15659504
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.
Woll PJ; Crowther D; Johnson PW; Soukop M; Harper PG; Harris M; Brampton MH; Newlands ES
Br J Cancer; 1995 Jul; 72(1):183-4. PubMed ID: 7599050
[TBL] [Abstract][Full Text] [Related]
11. The "old drug" dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas.
Zucali PA; Bertuzzi A; Parra HJ; Campagnoli E; Quagliuolo V; Santoro A
Invest New Drugs; 2008 Apr; 26(2):175-81. PubMed ID: 17898927
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer.
Dhodapkar M; Rubin J; Reid JM; Burch PA; Pitot HC; Buckner JC; Ames MM; Suman VJ
Clin Cancer Res; 1997 Jul; 3(7):1093-100. PubMed ID: 9815788
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.
Khan RB; Raizer JJ; Malkin MG; Bazylewicz KA; Abrey LE
Neuro Oncol; 2002 Jan; 4(1):39-43. PubMed ID: 11772431
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).
Dziadziuszko R; Ardizzoni A; Postmus PE; Smit EF; Price A; Debruyne C; Legrand C; Giaccone G;
Eur J Cancer; 2003 Jun; 39(9):1271-6. PubMed ID: 12763216
[TBL] [Abstract][Full Text] [Related]
15. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
Broniscer A; Iacono L; Chintagumpala M; Fouladi M; Wallace D; Bowers DC; Stewart C; Krasin MJ; Gajjar A
Cancer; 2005 Jan; 103(1):133-9. PubMed ID: 15565574
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of two-weekly temozolomide in patients with high-grade gliomas.
Wong S; Rosenthal MA; Dowling A; Jennens R; Woods AM; Ashley D; Cher L
J Clin Neurosci; 2006 Jan; 13(1):18-22. PubMed ID: 16356721
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.
Middleton MR; Grob JJ; Aaronson N; Fierlbeck G; Tilgen W; Seiter S; Gore M; Aamdal S; Cebon J; Coates A; Dreno B; Henz M; Schadendorf D; Kapp A; Weiss J; Fraass U; Statkevich P; Muller M; Thatcher N
J Clin Oncol; 2000 Jan; 18(1):158-66. PubMed ID: 10623706
[TBL] [Abstract][Full Text] [Related]
18. The Charing Cross Hospital experience with temozolomide in patients with gliomas.
Newlands ES; O'Reilly SM; Glaser MG; Bower M; Evans H; Brock C; Brampton MH; Colquhoun I; Lewis P; Rice-Edwards JM; Illingworth RD; Richards PG
Eur J Cancer; 1996 Dec; 32A(13):2236-41. PubMed ID: 9038604
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of temozolomide in advanced untreated pancreatic cancer.
Moore MJ; Feld R; Hedley D; Oza A; Siu LL
Invest New Drugs; 1998; 16(1):77-9. PubMed ID: 9740547
[TBL] [Abstract][Full Text] [Related]
20. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
Chamberlain MC; Tsao-Wei DD
Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
